Michael Petusky
Stock Analyst at Barrington Research
(2.38)
# 2,450
Out of 4,711 analysts
170
Total ratings
44.97%
Success rate
-2.19%
Average return
Main Sectors:
Stocks Rated by Michael Petusky
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HAE Haemonetics | Maintains: Outperform | $108 | $75.44 | +43.16% | 27 | Dec 4, 2024 | |
| USPH U.S. Physical Therapy | Maintains: Outperform | $108 | $91.31 | +18.28% | 21 | Nov 21, 2024 | |
| MODV ModivCare | Maintains: Outperform | $25 | $11.13 | +124.62% | 12 | Nov 18, 2024 | |
| VRME VerifyMe | Maintains: Outperform | $1.5 | $0.63 | +138.36% | 8 | Nov 13, 2024 | |
| OPK OPKO Health | Maintains: Outperform | $2.25 | $1.54 | +46.10% | 11 | Nov 8, 2024 | |
| XRAY DENTSPLY SIRONA | Maintains: Outperform | $36 → $24 | $18.70 | +28.34% | 19 | Nov 8, 2024 | |
| HSIC Henry Schein | Maintains: Outperform | $82 | $69.82 | +17.44% | 11 | Nov 6, 2024 | |
| LMAT LeMaitre Vascular | Maintains: Outperform | $92 → $93 | $92.12 | +0.96% | 8 | Nov 1, 2024 | |
| ANIK Anika Therapeutics | Maintains: Outperform | $37 → $25 | $16.31 | +53.28% | 15 | Nov 1, 2024 | |
| MMSI Merit Medical Systems | Maintains: Outperform | $114 | $98.22 | +16.07% | 15 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $40 → $32 | $22.91 | +39.68% | 11 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $7.24 | - | 6 | Aug 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $39.75 | - | 6 | May 30, 2024 |
Haemonetics
Dec 4, 2024
Maintains: Outperform
Price Target: $108
Current: $75.44
Upside: +43.16%
U.S. Physical Therapy
Nov 21, 2024
Maintains: Outperform
Price Target: $108
Current: $91.31
Upside: +18.28%
ModivCare
Nov 18, 2024
Maintains: Outperform
Price Target: $25
Current: $11.13
Upside: +124.62%
VerifyMe
Nov 13, 2024
Maintains: Outperform
Price Target: $1.5
Current: $0.63
Upside: +138.36%
OPKO Health
Nov 8, 2024
Maintains: Outperform
Price Target: $2.25
Current: $1.54
Upside: +46.10%
DENTSPLY SIRONA
Nov 8, 2024
Maintains: Outperform
Price Target: $36 → $24
Current: $18.70
Upside: +28.34%
Henry Schein
Nov 6, 2024
Maintains: Outperform
Price Target: $82
Current: $69.82
Upside: +17.44%
LeMaitre Vascular
Nov 1, 2024
Maintains: Outperform
Price Target: $92 → $93
Current: $92.12
Upside: +0.96%
Anika Therapeutics
Nov 1, 2024
Maintains: Outperform
Price Target: $37 → $25
Current: $16.31
Upside: +53.28%
Merit Medical Systems
Oct 31, 2024
Maintains: Outperform
Price Target: $114
Current: $98.22
Upside: +16.07%
Oct 31, 2024
Maintains: Outperform
Price Target: $40 → $32
Current: $22.91
Upside: +39.68%
Aug 28, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $7.24
Upside: -
May 30, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $39.75
Upside: -